Insider Trading April 7, 2026

Andersons Director Disposes $1.1 Million in Shares as Company Posts Mixed Q4 Results

Patrick E. Bowe sells 15,000 shares; Andersons reports EPS beat, revenue shortfall and amends credit facility

By Nina Shah ANDE
Andersons Director Disposes $1.1 Million in Shares as Company Posts Mixed Q4 Results
ANDE

Patrick E. Bowe, a director at Andersons, Inc., sold 15,000 shares on April 6, 2026, for $74.33 each, generating proceeds of $1,114,950. The transaction occurred with the stock trading near its 52-week high after a 104% one-year return. The company reported a fourth-quarter adjusted EPS beat but missed revenue expectations, and announced a reduction and extension to its revolving credit facility.

Key Points

  • Director Patrick E. Bowe sold 15,000 shares on April 6, 2026 at $74.33 per share, totaling $1,114,950; he now directly owns 129,874.6324 shares.
  • Andersons reported adjusted Q4 EPS of $2.04, beating the $1.56 analyst expectation, while revenue of $2.54 billion missed the $3.28 billion projection.
  • The company amended its credit agreement, reducing the revolving facility from $1.55 billion to $1.30 billion and extending the maturity dates of the revolver and a $114.3 million term loan to March 20, 2031; Benchmark reaffirmed a Buy rating with a $75.00 target.

Andersons, Inc. (NASDAQ: ANDE) reported an insider transaction and a set of fourth-quarter financial and financing updates that together paint a mixed operational and capital picture.

On April 6, 2026, director Patrick E. Bowe sold 15,000 shares of the companys common stock at $74.33 per share, for total proceeds of $1,114,950. The sale took place while the shares were trading close to their 52-week high of $74.94, following a 104% return over the prior year.

Following the disposition, Bowe directly holds 129,874.6324 shares of Andersons. The transaction was carried out under a Limited Power of Attorney executed by Melissa Trippel.


Alongside the insider sale, Andersons released fourth-quarter results showing adjusted earnings per share of $2.04, exceeding analyst expectations of $1.56. Revenue for the period was $2.54 billion, which was short of the $3.28 billion consensus projection.

The company attributed its strong earnings performance primarily to its Renewables and Agribusiness segments. Renewables generated $54 million in pretax income, a result the company linked to record ethanol production. Agribusiness produced $46 million in pretax income amid what the company described as a record corn harvest.

In a financing update, Andersons said it had amended its credit agreement. The amendment reduced the capacity of the companys revolving credit facility from $1.55 billion to $1.30 billion and extended the facilitys maturity to March 20, 2031. The maturity date for the companys $114.3 million term loan was also extended to March 20, 2031.

Benchmark maintained a Buy rating on the company and left its price target at $75.00, citing the companys fourth-quarter strength. The firm highlighted operational tailwinds and 45Z tax credits as key contributors to the positive results.

The disclosed insider sale, the mixed top-line and bottom-line results, and the credit agreement amendment together provide a snapshot of recent developments at Andersons that investors and market observers may weigh against the shares recent performance near the 52-week high.

Risks

  • Revenue for the quarter fell short of analyst projections, highlighting potential volatility in top-line performance that could affect investor sentiment and market valuation.
  • The reduction in revolving credit capacity from $1.55 billion to $1.30 billion may constrain near-term liquidity or financial flexibility relative to prior commitments.
  • An insider sale occurred while shares traded near a 52-week high, which may introduce uncertainty among shareholders about insider timing; the sale was executed under a Limited Power of Attorney.

More from Insider Trading

Perdoceo General Counsel Sells $1.14 Million in Stock as Board Confirms 2026 Incentive Plan Apr 7, 2026 Cathay General Bancorp CEO Executes $243,505 Stock Sale Under 10b5-1 Plan Apr 7, 2026 Guardant Health Chief People Officer Disposes of $355K in Shares Amid Rising Stock Apr 7, 2026 Gladstone Commercial Executive Reports Small Share Purchase as Q4 Results Outperform Apr 7, 2026 Security National Financial Director Sells 10,000 Shares in $94,500 Transaction Apr 7, 2026